CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
Conditions:
Generalized Pustular Psoriasis
Study Start (Actual) 2023-09-19
Primary Completion (Estimated) 2099-12
Study Completion (Estimated) 2099-12
Enrollment (Estimated) 200
Study Type OBSERVATIONAL
Phase N/A
Locations:
📍 Waltham, Massachusetts, United States

Eligibility Criteria

Description

    Inclusion Criteria:

    • * A subject must meet all the following criteria to participate in the registry:
    • 1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
    • 2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
    • 3. Is willing to provide consent for participation in the registry.
    • 4. Is willing to provide Personal Information

    Exclusion Criteria:

    • * Any of the following would exclude the subject from participating in the registry:
    • 1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.
    • 2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted2023-10-03
  • First Submitted that Met QC Criteria2023-10-23
  • First Posted2023-10-25

Study Record Updates

  • Last Update Submitted that Met QC Criteria2024-04-08
  • Last Update Posted2024-04-09
  • Last Verified2024-04